A Phase I Clinical Trial of FWD1802 in Patients With ER+/HER2- BC.
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer|Locally Advanced Breast Cancer|Breast Cancer Stage I|ER+ Breast Cancer
Interventions: DRUG: FWD1802|DRUG: palbocilib
Sponsor: Forward Pharmaceuticals Co., Ltd.